Morgan Stanley Upgrades St. Jude Medical, Optimistic on Guidance Achievability in 2014

In a report published Monday, Morgan Stanley analyst David Lewis upgraded St. Jude Medical (NYSE: STJ ) from Equal-weight to Overweight and announced a $75.00 price target. Lewis noted that Morgan Stanley is optimistic on guidance achievability in 2014 and St. Jude's pipeline. The analyst commented that Street estimates appear